Middle East & Africa Microbiology CRO Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
No. of Pages: 143 | Report Code: BMIRE00032144 | Category: Life Sciences
No. of Pages: 143 | Report Code: BMIRE00032144 | Category: Life Sciences
The Middle East & Africa microbiology CRO services market size is expected to reach US$ 254.65 million by 2031 from US$ 135.47 million in 2023. The market is estimated to record a CAGR of 8.2% from 2023 to 2031.
The Middle East & Africa microbiology CRO services market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of MEA. The microbiology CRO services market in the region is expected to grow owing to a few factors such as the rising prevalence of chronic diseases, growing number of clinical trials, increasing investments in the development of the healthcare industry, growing healthcare expenditure, and rise in several government initiatives and collaborations by market players.
Key segments that contributed to the derivation of the Middle East & Africa microbiology CRO services market analysis are application, service type, microorganisms, and end user.
Clinical trials are conducted to determine if a new form of medical product, drug, diet, or medical device is safe and effective. The trials are mainly a part of the overall drug development process. According to the National Library of Medicine (NLM), ~52,000 new studies were registered with NLM (ClinicalTrials.gov) in 2020, and the number increased to ~58,000 in 2023. In January 2023, the NLM reported 38,837 active clinical trials in the US and 105,172 active trials worldwide.
The increasing complexity of clinical trials makes the proper execution and monitoring of operations carried out in research-based organizations crucial. To avoid errors due to improper execution, many research-based organizations outsource clinical trials to clinical research organizations (CROs). Furthermore, CROs assist in successfully implementing clinical trials by offering deep subject matter expertise at high-quality facilities. They have gradually become an important part of the clinical trial industry through their efficient and cost-effective operations that benefit trial sponsors. According to a blog published by Thermo Fisher Scientific, in 2022, CROs executed ~3 out of 4 clinical trials to reassure the clinical programs of drug developers; provide a wealth of expertise; drive time and cost efficiencies; and deliver customized, high-quality data.
Awareness about the importance of microbiology testing in ensuring the quality and safety of products, particularly in the fields of vaccines, biologics, drugs, and medical devices, is increasing. Microbial testing is essential in clinical trials where the integrity of study results relies heavily on accurate microbiology testing. As pharmaceutical companies and biotech firms focus on their core competencies, they are increasingly relying on CROs to manage their clinical trial testing needs. Thus, the increasing number of clinical trials and the practice of outsourcing trials to CROs to boost cost-effectiveness and reduce errors drive the microbiology CRO market.
Based on country, the Middle East & Africa microbiology CRO services market comprises South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. South Africa held the largest share in 2023.
The rising number of strategic initiatives by private and government organizations fuels the growth of the microbiology CRO services market in South Africa. The Center for Infectious Diseases Research in Africa (CIDRI-Africa) supports investigator-led approaches with the overarching scientific objective of combatting infection, particularly human immunodeficiency virus-1, tuberculosis, and Lower Respiratory Tract Infections through clinical and laboratory research. In August 2024, the Chan Soon-Shiong Family Foundation (CSSFF)—South Africa Medical Research Council (SAMRC) Capacity Development Programme was initiated. This partnership between CSSFF and SAMRC aims to train and build an Africa-based workforce and innovation pipeline for vaccine development, testing, and manufacturing. The program is designed to enhance Africa's health and biotechnology human capital and to grow Africa's workforce in vaccine manufacturing. Such initiatives have a positive impact on the microbiology CRO services market growth. Further, CROs such as Novotech, OnQ Research, and LT Clinical Research (Pty) Ltd, operating in South Africa, provide microbiology services.
Thus, the growing number of initiatives supporting microbial testing and the rising number of microbiology CROs in South Africa are likely to create opportunities for the microbiology CRO services market growth during the forecast period.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 135.47 Million |
| Market Size by 2031 | US$ 254.65 Million |
| CAGR (2023 - 2031) | 8.2% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Application
|
| Regions and Countries Covered | Middle East and Africa
|
| Market leaders and key company profiles |
|
Some of the key players operating in the market include Microbiologics; Melbec Microbiology; Emery Pharma; TheraIndx Lifesciences Pvt. Ltd.; AVERIN BIOTECH; Statens Serum Institut; ImQuest BioSciences; PACIFIC BIOLABS; Innovotech Inc.; and BluTest Laboratories Ltd among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
The Middle East & Africa Microbiology CRO Services Market is valued at US$ 135.47 Million in 2023, it is projected to reach US$ 254.65 Million by 2031.
As per our report Middle East & Africa Microbiology CRO Services Market, the market size is valued at US$ 135.47 Million in 2023, projecting it to reach US$ 254.65 Million by 2031. This translates to a CAGR of approximately 8.2% during the forecast period.
The Middle East & Africa Microbiology CRO Services Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Microbiology CRO Services Market report:
The Middle East & Africa Microbiology CRO Services Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Microbiology CRO Services Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Microbiology CRO Services Market value chain can benefit from the information contained in a comprehensive market report.
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Microbiology CRO Services Market
